Results
8604
Companies with a Future performance score of at least 3, ordered by Future performance score.
8,604 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MX1 | AU$0.07 | -4.1% | -46.2% | AU$40.7m | AU$0.19 | PS2.7x | E68.6% | n/a | Healthcare | ||
PRL | CA$39.74 | 12.4% | 364.3% | CA$1.4b | CA$41.43 | PE22.7x | E37.1% | 1.4% | Diversified Financials | ||
BTR | AU$0.025 | 6.5% | 75.0% | AU$174.8m | AU$0.05 | PS165.7x | E84.6% | n/a | Materials | ||
NEWBRY | SEK 3.90 | 1.0% | 6.8% | SEK 94.6m | SEK 8.00 | PS2.6x | E130.0% | n/a | Pharmaceuticals & Biotech | ||
MBTN | CHF 1.17 | -19.5% | -99.4% | CHF 36.1m | CHF 6.03 | PS0.4x | E111.6% | n/a | Semiconductors | ||
505283 | ₹1,653.05 | -2.1% | 195.8% | ₹107.2b | ₹1,833.00 | PE56.5x | E26.3% | 0.4% | Capital Goods | ||
EH | US$16.51 | -3.2% | 27.1% | US$1.0b | US$24.35 | PS30.1x | E81.4% | n/a | Capital Goods | ||
AV1 | AU$0.084 | 2.4% | 61.5% | AU$66.3m | AU$0.22 | PS15.9x | E144.2% | n/a | Software | ||
FND | AU$6.57 | 2.8% | 726.4% | AU$322.1m | AU$6.73 | PE79.8x | E64.8% | n/a | Diversified Financials | ||
DOMS | ₹2,771.65 | -2.7% | n/a | ₹168.2b | ₹2,641.29 | PE90.6x | E20.8% | 0.09% | Commercial Services | ||
CRDO | US$48.00 | 18.7% | 199.1% | US$8.0b | US$37.58 | PS36.6x | E95.0% | n/a | Semiconductors | ||
SCOL | SEK 0.072 | -27.5% | -94.2% | SEK 16.8m | SEK 0.60 | PB0.4x | E75.3% | n/a | Pharmaceuticals & Biotech | ||
AGP | €6.95 | -6.1% | 44.8% | €120.3m | €12.85 | PE17.8x | E22.1% | n/a | Capital Goods | ||
TGTX | US$28.81 | 7.1% | 181.9% | US$4.1b | US$37.22 | PS15.6x | E56.5% | n/a | Pharmaceuticals & Biotech | ||
MVW | NOK 9.80 | -7.5% | 45.4% | NOK 320.6m | NOK 12.20 | PS18.6x | E70.8% | n/a | Materials | ||
156A | JP¥643.00 | -5.6% | n/a | JP¥6.3b | n/a | PE8.9x | E24.0% | 3.9% | Media | ||
CCOLA | ₺45.70 | -9.9% | 16.2% | ₺127.9b | ₺85.53 | PE10x | E42.0% | 1.6% | Food, Beverage & Tobacco | ||
PHM | €77.25 | 4.5% | 123.1% | €1.4b | €84.60 | PE2178.3x | E56.4% | 0.8% | Pharmaceuticals & Biotech | ||
ARES | US$170.38 | 5.3% | 58.1% | US$53.7b | US$171.08 | PE78.3x | E33.3% | 2.2% | Diversified Financials | ||
CADLR | NOK 69.20 | -6.5% | 101.3% | NOK 24.3b | NOK 81.79 | PS16.7x | E68.0% | n/a | Capital Goods | ||
ZVRA | US$9.00 | 7.1% | 116.9% | US$473.6m | US$20.43 | PS20x | E69.7% | n/a | Pharmaceuticals & Biotech | ||
ACI | ₹679.80 | 4.6% | 26.3% | ₹83.9b | ₹890.14 | PE38.2x | E42.1% | 0.4% | Materials | ||
AXSM | US$90.07 | 1.4% | 56.9% | US$4.3b | US$125.29 | PS14.8x | E69.2% | n/a | Pharmaceuticals & Biotech | ||
YGG | ฿0.65 | -19.8% | -91.2% | ฿391.3m | ฿10.75 | PS1.4x | E85.5% | 41.2% | Media |